Modeling immune checkpoint blockade using idenTx
One of the major challenges in developing successful cancer therapies is the inhibitory effect caused by immune checkpoint resistance, normally including the PD-1 checkpoint protein in T cells that we’ve highlighted in previous posts. As a result, in vitro models that...
Featured study: Building a new way to emulate the pancreatic tumor microenvironment for immunotherapy
The challenge To obtain significant results when studying cancer therapies, mimicking the human tumor microenvironment is critical if any such results are to be extrapolated to human treatments. In particular, pancreatic tumors present a challenge not readily met by...
Scale up your study without compromise: Introducing the idenTx 40 plate
Meet the idenTx 40. Using the same technology as our proven idenTx 3 chip, scaled to accommodate 40 independent experiments fully integrated into a standard SBS plate format. The idenTx 40 Plate handles just like any other SBS plate and is ready to fit right into your...
European Parliament votes to end animal testing in favor of using human models
In a major win for animal rights and an equally major validation of humanized preclinical models, the European Parliament has approved a resolution aimed at phasing out lab animal testing in favor of alternative modern technology, like organ-on-a-chip models. Citing...